TRexBio Completes $26 Million Series A Extension Led by Polaris Partners to Advance Treatments for Immune-Mediated Diseases
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #Biotech--TRexBio has completed a $26 million extension of its Series A financing in a round led by new investor Polaris Partners.
